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a  b  s  t  r  a  c  t
The  nematode  Spirocerca  lupi  (S. lupi)  induces  sarcoma  in  the  dog  oesophagus  in  about
25%  of cases.  The  aim  of  this  study  was  to compare  the  differences  in  the  cytokine  milieu
between  dogs  with  neoplastic  (n =  29)  and  non-neoplastic  disease  (n =  49) and  age- and
gender-matched  healthy  controls  (n = 25).  We  measured  IL-2, IL-4, IL-6,  IL-8,  IL-10,  IL-18,
GM-CSF and MCP-1  in  a speciﬁc  canine  multiplex  immunoassay  kit.  Cytokine  concentra-
tions  were  compared  between  the  different  groups  using  the  Kruskal–Wallis  test followed
by Dunn’s  test.
Only  IL-8  and  IL-18  showed  signiﬁcant  differences  in their  plasma  concentration  among
the  three  groups.  Kruskal–Wallis  test  revealed  a signiﬁcant  (p  =  0.001)  difference  in  IL-8
concentration  between  the  neoplastic  group  (634 pg/ml),  the non-neoplastic  (429  pg/ml)
and the  control  groups  (150  pg/ml).  Post-test  analysis  revealed  a signiﬁcance  difference
between  the  two  S. lupi  groups  and  the  control  group  (p <  0.01).  The  highest  IL-18  concen-
tration  was  found  in the  non-neoplastic  group  (53  pg/ml),  followed  by the  control  group
(46 pg/ml)  and  ﬁnally  the  neoplastic  group  (33 pg/ml).  IL-18  concentrations  were  signiﬁ-
cantly higher  in  the  non-neoplastic  group  than  in  the  neoplastic  group  (p  = 0.05).The increased  IL-8  in the  spirocercosis  groups  is  consistent  with  the  neutrophilic  inﬁl-
trate in spirocercosis  lesions  and in  those  of  other  inﬂammatory-induced  neoplasias  such
as Barret’s  oesophagus  and  Helicobacter  gastritis.  IL-18  showed  negative  regulatory  effect
in several  worm  infections  and  it is possible  that  it plays  the  same  role  in  spirocercosis,
allowing  the worm  to  evade  the  host  response  and  to induce  neoplastic  transformation.. IntroductionSpirocercosis is a disease caused by the Spirocerca lupi
S. lupi) nematode in dogs (Bailey, 1972). The disease occurs
orldwide throughout tropical and subtropical areas, in
ery high prevalence in certain locations (Dvir et al., 2001).
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In South Africa the prevalence in some areas may  reach
up to 70% (Kok et al., 2010). At the end of the migra-
tion route within the dog the adult worm settles in a
ﬁbro-inﬂammatory nodule in the caudal oesophagus (Dvir
et al., 2010). These nodules transform to a sarcoma in
approximately 25% of cases (Dvir et al., 2001). The ini-
tial non-neoplastic nodule shows marked inﬂammation
that involve myeloid cells (predominantly neutrophils) and
lymphoplasmacytic cells (with high prevalence of CD3+ T
cells and to a lesser degree Pax5+ B cells) (Dvir et al., 2011).
There is also evidence of an increased systemic inﬂamma-
tory response in both the neoplastic and non-neoplastic
stages that is reﬂected as a leukocytosis (Dvir et al., 2008)
and an elevated C-reactive protein (CRP) (Mukorera et al.,
2011).
Parasito186 E. Dvir et al. / Veterinary 
The association between chronic infection-induced
inﬂammation and cancer is now well-described and is
thought to be the mechanism responsible for up to 18%
of cancers globally (Vennervald and Polman, 2009). In
terms of parasite-associated malignancies, three helminth
infections have been classiﬁed as carcinogenic in humans,
namely Schistosoma haematobium,  Clonorchis sinensis and
Opisthorchis viverrini (Vennervald and Polman, 2009),
while Schistosoma mansoni (S. mansoni) is suspected to be
carcinogenic (Yoshida et al., 2002). In dogs, oesophageal
sarcoma (excluding leiomyosarcoma) is almost invari-
ably associated with S. lupi infections, whereas in human
oncogenic helminth-associated neoplasia the association
is limited to only a portion of the speciﬁc cancer cases
(Herrera et al., 2005), making spirocercosis a highly attrac-
tive model to study the association between cancer,
helminth infection and inﬂammation.
Our central hypothesis, while investigating the neo-
plastic transformation and the inﬂammatory response
in canine spirocercosis, was that the parasite produces
excretory product(s) which diverts the immune response
from a T helper 1 (Th1) to Th2 cell response, typ-
ical of many nematode infections, and further to an
immunoregulatory (immunosuppressive), FoxP3+ regula-
tory T cell-predominated response which then facilitates
neoplastic transformation. This immune response is well-
described across species. It is associated with ﬁbroblastic
proliferation and has been classiﬁed as a delayed hypersen-
sitivity type 3 (Meeusen, 1999). The potential link between
switching from Th1 to Th2 response and cancer formation
was demonstrated in S. mansoni-infected mice that were
injected with ﬁbrosarcoma cells. The infected mice had up-
regulation of their Th2 responses and consequently had
a signiﬁcantly weaker rejection of the cancer cells com-
pared to the non-infected mice that showed Th1 response
and stronger rejection (Yoshida et al., 2002). Increased
numbers and proportions of Foxp3+ Tregs within tumours
are well described in humans (Carreras et al., 2006; Unitt
et al., 2005; Xue et al., 2009) and murine models (Imai
et al., 2007), including models of ﬁbrosarcoma (Betts et al.,
2007). Surprisingly, Foxp3+ cells are rarely observed in S.
lupi-associated oesophageal nodules and when present, are
usually in very small numbers (Dvir et al., 2011). However,
they are found in large numbers within CD3+ regions of the
bronchial lymph nodes that are draining these lesions (Dvir
et al., 2011). These ﬁndings cannot completely exclude
the possibility of Treg-associated immunosuppression dur-
ing the neoplastic transformation in spirocercosis and one
potential mechanism is a systemic response driven by cir-
culating cytokines. It is, therefore imperative to investigate
the cytokine milieu in canine spirocercosis and to deter-
mine if it is Th1-related, Th2-related, immunosuppressive
or pro-inﬂammatory.
Since cytokines work in networks, several canine
plasma cytokines including GM-CSF, IL-2, IL-4, IL-6, IL-
8, IL-10, IL-18 and MCP-1 should be measured. Of these
cytokines IL-2, IL-6, IL-8 and IL-18 are pro-inﬂammatory
and IL-4 and IL-10 are immunoregulatory. The pro-
inﬂammatory cytokines such as IL-2 enhance the cytolytic
activity of T lymphocytes and NK cells (Antony and
Dudek, 2010). It is a Th1-related-interleukin and has majorlogy 190 (2012) 185– 190
anti-tumour activity. IL-2 works synergistically with IL-18
(Srivastava et al., 2010). IL-6 is another pro-inﬂammatory
cytokine that is classiﬁed as a major pro-tumourogenic
cytokine. It serves as a growth and survival factor that
stimulates angiogenesis, tumour progression and metas-
tasis, and it is reported to maintain tumour-promoting
inﬂammation (Grivennikov and Karin, 2011). Cancer cells,
including tumour-associated ﬁbroblasts, are also capa-
ble of IL-6 production and can signiﬁcantly contribute
to the serum concentration of this cytokine (Grivennikov
and Karin, 2011). Elevated IL-6 was  suggested as a use-
ful biomarker for poor prognosis in dogs with cancer (Itoh
et al., 2009), yet it was  also successfully used as therapy in
dogs with transmissible venereal tumours demonstrating
anti-tumour activity (Chou et al., 2009).
Interleukin-8 is another pro-inﬂammatory cytokine
that is expected to be elevated in malignancy. It is
regarded as a signiﬁcant regulatory factor within the
tumour microenvironment and is produced by various
inﬂammatory cells, but also by tumour cells (Waugh
and Wilson, 2008). Secretion of IL-8 from cancer cells
can enhance their proliferation and survival, promote
angiogenesis and induce chemotactic inﬁltration of neu-
trophils into the tumour site. Elevated serum IL-8 was
correlated with tumour progression in humans with
oesophageal squamous cell carcinoma (Diakowska et al.,
2006; Krzystek-Korpacka et al., 2008). It was also detected
in Barret’s oesophagus (Fitzgerald et al., 2002), a human
condition that involves oesophageal inﬂammation due to
inﬂux, epithelial dysplasia and metaplasia and eventually
neoplastic transformation. The expression of IL-8 increases
as the diseases progresses to cancer (Oh et al., 2007).
IL-18, like IL-2, enhances cytolytic activity of natural
killer (NK) cells and cytotoxic T lymphocytes. IL-18 is a
critical molecule in the activation of the Th1 immune
response (Park et al., 2007). Like many cytokines, IL-18
has dual effects in cancer progression; namely enhancing
anti-tumour immunity and promoting tumour progression
(Park et al., 2007). Higher expression or secretion of IL-
18 is detected in various cancer cells in comparison with
normal controls and IL-18 is able to induce tumour angio-
genesis, migration/metastasis, proliferation and immune
evasion (Park et al., 2007). IL-18 stimulates production of
vascular endothelial growth factor (VEGF) mRNA and the
ﬁnal protein product leading to angiogenesis (Park et al.,
2007). VEGF is highly expressed in spirocercosis-induced
neoplasia (Dvir and Clift, 2010). Elevated serum IL-18 was
found in humans with oesophageal squamous cell carci-
noma and correlated with tumour progression (Diakowska
et al., 2006; Krzystek-Korpacka et al., 2008).
IL-4 is a typical Th2-related cytokine and is therefore,
not “expected” to have a major anti-tumour effect. In
fact, many Th2-related cytokines are regarded as immuno-
suppressive and “tumour promoting”. This approach has,
however, been proven to be over-simplistic, because
IL-4 can also contribute to tumour rejection by boost-
ing eosinophil function and increased antibody reaction
(Dranoff, 2004). Therefore, it is not surprising that therapy
with IL-4 shows an anti-tumour effect (Dranoff, 2004). IL-
10 is the typical immunoregulatory cytokine, being a Treg-
and Th2-related cytokine. It is widely believed that Treg
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unction in cancer is mainly to suppress protective anti-
ancer inﬂammatory responses (Beyer and Schultze, 2006).
he role of Treg and the associated IL-10 is paradoxical,
ince IL-10 and Treg also reduce inﬂammation associated
ith infectious diseases (“hygiene theory”). This ability to
educe inﬂammation consequently inhibits or suppresses
ancer (Erdman and Poutahidis, 2010).
Granulocyte-macrophages colony-stimulated factor
GM-CSF) is important in the process of protection from
nfection-induced cancer. GM-CSF/INF- double-knockout
ice developed diverse haematological and solid neo-
lasms after various chronic infections and inﬂammations
Dranoff, 2004). GM-CSF is also used as an adjuvant in
nti-cancer therapy in a few types of cancer in clinical tri-
ls. However, as many other cytokines, GM-CSF has a dual
ffect in cancer immunity and it also promotes invasion
nd dissemination of breast carcinoma in a transgenic
ouse model.
Monocyte chemotactic protein-1 (MCP-1) is a
hemokine that was originally termed ‘tumour derived
hemotactic protein’. It is secreted by several tumour cell
ines and it is a potent chemotactic protein for monocytes,
eutrophils, memory T cells and NK cells as well as stimu-
ant for emigration of myeloid cells from the bone marrow
Perry et al., 2010). The early (non-neoplastic) spirocercosis
odules consist of massive pockets of MAC387+ myeloid
ells (Dvir et al., 2011). It is likely that this response is
 normal innate response to the pathogen. Expression
f MCP-1 is a biomarker for poor outcomes in breast
arcinoma and ovarian cancer in humans and it has been
ssociated with a poor prognosis in dogs diagnosed with
ymphoma (Perry et al., 2010). Therefore, it is of interest to
nvestigate its level in the different stages of spirocercosis.
In summary, it is of great interest to investigate the
ytokine milieu and especially this set of cytokines in
pirocercosis. We  hypothesise that the cytokines expressed
n spirocercosis (an infectious disease that progress to
ggressive cancer with marked inﬂammation) will serve
s biomarkers for neoplastic transformation and provide
nsights into the pathogenesis of this process.
. Material and methods
.1. Study population
The study population comprised of client-owned dogs
dmitted to the Onderstepoort Veterinary Academic Hos-
ital, at the Faculty of Veterinary Science, University of
retoria between 2008 and 2011. The study was approved
y the faculty’s animal use and care committee. The dogs
ere divided into 3 groups, non-neoplastic, neoplastic and
ealthy controls.
An initial diagnosis of spirocercosis was made by one of
he following criteria: a faecal ﬂoat that was positive for S.
upi worm eggs or radiological signs consistent with S. lupi
nfection, namely caudodorsal mediastinal mass together
ith spondylitis of the caudal thoracic vertebrae or undu-
ation of the lateral border of the descending aorta (2
athognomonic radiological signs associated with spiro-
ercosis).ogy 190 (2012) 185– 190 187
Classifying the mass as non-neoplastic was  done by one
of the following criteria:
• The masses had the typical smooth appearance of non-
neoplastic nodules on endoscopy and responded to
treatment monitored by follow-up endoscopy at 6 weeks
and again at 12 weeks, if a poor initial response was
shown at 6 weeks.
• Histopathological evaluation of the entire oesophageal
nodule showed no evidence of neoplastic transformation.
The sample was  obtained by either surgical excision of
the mass or necropsy.
Classifying the mass as neoplastic was  performed by one
of the following criteria:
• Histopathological diagnosis of neoplastic transformation
by endoscopy-guided biopsy or post-necropsy.
• Metastatic lesions in the lungs, together with radiologi-
cal signs associated with S. lupi and no other diagnosed
neoplasm.
Cases that could not be classiﬁed as non-neoplastic or
neoplastic were excluded (n = 3).
The control group was  composed of dogs that were
presented for ovariohistorectomy, castration or blood
donation. They were healthy by deﬁnition, had a full clinical
history and had normal clinical examination and haema-
tology. All dogs were negative for spirocercosis on faecal
ﬂoatation and most of the dogs had thoracic radiographs
and all thoracic radiographs were negative for S. lupi.
They were age- and gender-matched with the other study
groups.
2.2. Patient sampling
Blood samples were collected at admission by jugular
veinpuncture with a 21 g needle and a 5 ml  potassium EDTA
vacutainer syringe. The samples were then immediately
centrifuged, separated, aliquoted and frozen at −80 ◦C. The
samples were batched and analysed together.
2.3. Analyses
Plasma cytokine concentrations were assessed at the
department of Small Animal Clinical Sciences, University
of Copenhagen, Denmark by a canine-speciﬁc multi-
plex assay (CCYTO-90K, Millipore, Billerica, MA)  including
internal quality control material with an automated ana-
lyzer (Luminex 200, Luminex Corporation, Austin, TX) for
interleukin-2 (IL-2), IL-4, IL-6, IL-8, IL-10, IL-18, MCP-1 and
GM-CSF (Kjelgaard-Hansen et al., 2011).
2.4. Data analysis
The median of each cytokine plasma concentration of
each group was  calculated and compared between groups
using Kruskal–Wallis test, followed by Dunn’s test for dif-
ferences between speciﬁc pairs of groups. The level of
signiﬁcance was set at p ≤ 0.05.
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3. Results
One hundred and three dogs were enrolled in the study
and were divided into 3 groups, non-neoplastic (n = 49),
neoplastic (n = 29) and healthy control (n = 25). Seventy
six out of the 78 dogs with spirocercosis had oesophageal
endoscopy performed and the typical oesophageal S. lupi
nodule(s) were identiﬁed. The 49 non-neoplastic cases
had the typical smooth appearance and responded to
doramectin treatment. Twenty seven neoplastic cases
had the characteristic cauliﬂower-like appearance on
endoscopy and/or necropsy with area of necrosis and ulcer-
ation and were diagnosed by histopathology as sarcoma.
The remaining 2 cases were neoplastic cases that were
diagnosed based on the pathognomonic radiological signs
and metastases in the lungs. The neoplastic nature of the
lesion was later conﬁrmed by necropsy in 1 of the 2 cases.
Interleukin 2, IL-4, IL-6, IL-10, MCP-1 and GM-CSF con-
centrations were not signiﬁcantly different between the
three groups. Only IL-8 and IL-18 showed signiﬁcant dif-
ferences in their plasma concentrations among the three
groups. The highest median IL-8 concentration was  in
the neoplastic group [634 pg/ml, interquartile range (IR),
309–1230], followed by the non-neoplastic (429 pg/ml,
IR 161–1277) and the control groups (150 pg/ml, IR
33–446). Post-test analysis revealed a signiﬁcance differ-
ence between the two S. lupi groups and the control group
(neoplastic vs. control, p = 0.002 and non-neoplastic vs.
control, p = 0.003). The highest IL-18 concentration was
in the non-neoplastic group (53 pg/ml, IR 25–156), fol-
lowed by the control group (46 pg/ml, IR 24–264) and
ﬁnally the lowest concentration was found in the neoplastic
group (33 pg/ml, IR 1.6–79). Post-test analysis revealed that
IL-18 concentrations were signiﬁcantly higher in the non-
neoplastic group than in the neoplastic group (p = 0.05).
There was a trend toward a low IL-2 in the neoplastic group
compared to the non-neoplastic and the control groups
(Table 1).
4. Discussion
This study investigated key plasma cytokine concen-
trations in canine spirocercosis. Although this disease is
associated with a severe systemic and local inﬂammatory
response (Dvir et al., 2011; Mukorera et al., 2011), the
plasma cytokine milieu has never been investigated. The
most signiﬁcant ﬁnding in this study is the increased con-
centration of IL-8 in the spirocercosis group and especially
the neoplastic group. However, despite a marked difference
between the median IL-8 plasma concentration between
the neoplastic and the non-neoplastic groups (634 pg/ml
and 429 pg/ml, respectively), the difference was not signif-
icant, most probably due to the wide range within each
group and the substantial overlap between the ranges
[interquartile range (IR), 309–1230, and 161–1277, respec-
tively]. IL-8 is a chemoattractant for neutrophils, which
in turn can also produce IL-8 (Wiinberg et al., 2005). The
high concentrations of IL-8 seen in this study is, there-
fore, in agreement with previous studies that showed
an intense neutrophilic inﬂammatory reaction within the
nodule (Dvir et al., 2010, 2011), neutrophilia (Dvir et al.,logy 190 (2012) 185– 190
2008) and elevated serum CRP (Mukorera et al., 2011).
Interestingly, a recent publication described an increased
activation of canine neutrophils with increased produc-
tion of IL-8 as a response to Wolbachia surface protein
(Bazzocchi et al., 2003). Wolbachia is an endosymbiont
of Diroﬁlaria immitis and Diroﬁlaria repens and the study
speculates that these ﬁndings can explain some of the
inﬂammatory features of diroﬁlariosis in the dog. It is pos-
sible that S. lupi also harbours bacteria that are responsible
for the inﬂammatory response, which may  explain why  the
inﬂammatory features are different from what is expected
in helminth infection (namely elevated Th2- and Treg-
associated cytokines). Interestingly, Wolbachia was  found
to be associated with tumour development in a ﬁlariae
called Onchocerca volvulus and treating the bacteria with
doxycycline reduced the incidence of tumour develop-
ment in this ﬁlariae (Brattig et al., 2010), emphasizing the
oncogenic potential of those endobacteria. The association
between up-regulated IL-8 and bacterial infection-induced
cancer is well demonstrated in Helicobacter pylori (H.
pylori)-induced chronic gastritis in humans, where it is
proposed to play a role in the neoplastic transformation
to adenocarcinoma (Wiinberg et al., 2005). IL-8 was  also
highly expressed in dogs infected with Helicobacter spp
(Wiinberg et al., 2005), correlating with the intensity of
the infection-associated neutrophilic inﬁltrate (Wiinberg
et al., 2005). However, H. pylori infection is more associ-
ated with lymphocytic hyperplasia, where IL-8 is highly
expressed in correlation with the lymphocytic inﬁltrate
(Straubinger et al., 2003), which is the second most com-
mon  inﬂammatory inﬁltrate in spirocercosis. IL-8 was
uniformly over-expressed in dogs with osteosarcoma and
its expression was associated with poor outcome in pae-
diatric osteosarcoma patients (Paoloni et al., 2009). This is
of speciﬁc interest, considering the fact that osteosarcoma
is the most common spirocercosis-associated tumour (Dvir
et al., 2010).
Another condition, where the cytokine milieu is quite
similar to this study, namely increased IL-8 and no change
in IL-4 and IL-10, is gastro-oesophageal reﬂux disease
and especially Barrett’s oesophagus in humans (Jenkins
et al., 2007; Rieder et al., 2010). In Barrett’s oesopha-
gus there is also further increases in IL-8 as the disease
progresses to adenocarcinoma and it is found to be up-
regulated by NF-b (Jenkins et al., 2007). The possibility
that spirocercosis-induced cancer can serve as a model
for Barret’s oesophagus-induced cancer warrants further
investigation, as this is an emerging cause of oesophageal
cancer in the western world. In reﬂux oesophageal diseases
in humans, IL-8 is also secreted by ﬁbroblasts, epithelial
and endothelial cells and because it is a potent chemoat-
tractant of neutrophils that further secrete IL-8, it creates a
spiral of inﬂammation and damage leading to further injury
(Jenkins et al., 2007). This cascade of events can also happen
in spirocercosis in the dog, where ﬁbroblasts are abun-
dant (Dvir et al., 2010). The question remains, whether the
innate response, and its potentially associated increased
IL-8 expression, has a role in the neoplastic transformation.
IL-18, a typical pro-inﬂammatory cytokine that induces
IFN- production and stimulates Th1 immune responses,
was  signiﬁcantly lower in the neoplastic group compared
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Table 1
The different cytokines plasma concentrations (pg/ml) in the different groups.
Cytokine Detection limit (DL) Neoplastic Non-neoplastic Control
Median Interquartile range Median Interquartile range Median Interquartile range P
IL-2 6.4 18 7–72 38 17–137 28 9–233 0.18
IL-4  28.8 <DL <DL to <DL <DL <DL to <DL <DL <DL to <DL 0.65
IL-6  12.1 <DL <DL to <DL <DL <DL to <DL <DL <DL to <DL 0.99
IL-8  20.3 634 309–945 429 161–1277 150 34–446 <0.01
IL-10 1.6  <DL <DL to 7 <DL <DL to 4 <DL <DL to <DL 0.26
IL-18 4.6 33 1.6–79 53 25–156 46 24–264 0.05
MCP-1 8.6  209 100–334 163 116–377 142 101–276 0.43
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o the non-neoplastic group. In the current study it is not
lear if the reduced IL-18 is related to spirocercosis infec-
ion, because the non-neoplastic group was not different
rom the control and in the neoplastic cases the worm is
ften not present any more (Dvir et al., 2010). However,
he possibility that the low IL-18 is related to prolonged
. lupi infection, evasion of the host response and the neo-
lastic transformation cannot be excluded. Decreased IL-18
s unusual in cancer patients, but decreased Th1 cytokines
uch as IL-18 is commonly observed in chronic helminth
nfections across species. There are, however, a few reports
f increased IL-18 in a number of nematodes infections
uch as Trichuris muris (Grencis, 2001) and Trichinella spi-
alis (Helmby and Grencis, 2002) and trematodes infections
uch as S. mansoni (Hogg et al., 2003) and Schistosoma
aponicum (He et al., 2002). One mechanisms in which IL-18
lays a role in down-regulating the normal anti-helminth
esponse is by inhibiting mast cells function (Helmby et al.,
001), but there is also contrasting evidence showing that
L-18 treatment is associated with prominent mastocyto-
is and increased expulsion of Strongyloides venezuelenzis
n mice (Sasaki et al., 2005). Clinical studies, such as ours
annot establish cause and effect relationships, but indi-
ate that the role of IL-18 in canine spirocercosis warrants
urther investigation.
Chronic helminth infections are often associated with
ncreased Th2-associated cytokines, such as IL-4 and IL-10,
 pattern that was also described in dogs with D. immitis
Morchon et al., 2007). In Toxocara canis infection in the dog
he production of the Th2- and Treg-associated cytokine, IL-
0, is increased while the production of the Th1-associated
ytokines, IL-18 and INF- are decreased (Torina et al.,
005). Such a response is often described as “immunoreg-
latory” or “immunosuppressive” and because it also
romotes or is associated with cancer formation, our
entral hypothesis was that these cytokines would be
ncreased in the S. lupi cases, especially the ones with the
eoplastic transformation. However, this was not the case
nd IL-4 and IL-10 showed very low concentrations in the
. lupi groups as well as the controls. We  have considered
he possibility that these results might be kit dependent,
owever, the respective kits’ detection limits (1.6 pg/ml)
s much lower than the IL-10 concentrations that was
eported in dogs in a study that was performed in our lab-
ratory (Kjelgaard-Hansen et al., 2007).
Our study aim was also to assess if any of the investi-
ated cytokines may  serve as a biomarker for neoplastic18–145 35 17–172 0.62
transformation. In that respect elevated IL-8 might indi-
cate neoplastic transformation, while high IL-18 indicated
non-neoplastic transformation.
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